Protein-protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategies

被引:14
|
作者
Lucero, Bobby [1 ]
Francisco, Karol R. [2 ]
Liu, Lawrence J. [1 ]
Caffrey, Conor R. [2 ]
Ballatore, Carlo [3 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA
关键词
DIRECTED TOSYL CHEMISTRY; NATIVE FKBP12; IN-VITRO; INHIBITORS; COMPLEXES; DISCOVERY; DESIGN; MCL-1;
D O I
10.1016/j.tips.2023.04.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The development of small-molecule inhibitors or stabilizers of selected protein- protein interactions (PPIs) of interest holds considerable promise for the devel-opment of research tools as well as candidate therapeutics. In this context, the covalent modification of selected residues within the target protein has emerged as a promising mechanism of action to obtain small-molecule modulators of PPIs with appropriate selectivity and duration of action. Different covalent labeling strategies are now available that can potentially allow for a rational, ground-up discovery and optimization of ligands as PPI inhibitors or stabilizers. This review article provides a synopsis of recent developments and applications of such tac-tics, with a particular focus on site-directed fragment tethering and proximity -enabled approaches.
引用
收藏
页码:474 / 488
页数:15
相关论文
共 50 条
  • [1] Small-molecule inhibitors of protein-protein interactions
    Berg, Thorsten
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (05) : 666 - 674
  • [2] Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors
    Li, Bingbing
    Rong, Deqin
    Wang, Yuanxiang
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (21) : 1872 - 1876
  • [3] Targeting epigenetic protein-protein interactions with small-molecule inhibitors
    Linhares, Brian M.
    Grembecka, Jolanta
    Cierpicki, Tomasz
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (14) : 1305 - 1326
  • [4] Small-molecule inhibitors of cancer-relevant protein-protein interactions
    Kiessling, A.
    Schust, J.
    Mueller, J.
    Sperl, B.
    Reindl, W.
    Hollis, A.
    Berg, T.
    ONKOLOGIE, 2008, 31 : 16 - 16
  • [5] Small-Molecule Inhibitors of Protein-Protein Interactions: How to Mimic a Protein Partner
    Fry, David C.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4679 - 4684
  • [6] Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
    Arkin, Michelle R.
    Tang, Yinyan
    Wells, James A.
    CHEMISTRY & BIOLOGY, 2014, 21 (09): : 1102 - 1114
  • [7] Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream
    Arkin, MR
    Wells, JA
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) : 301 - 317
  • [8] Turning Peptide Ligands into Small-Molecule Inhibitors of Protein-Protein Interactions
    Hashimoto, Chie
    Eichler, Jutta
    CHEMBIOCHEM, 2015, 16 (13) : 1855 - 1856
  • [9] Covalent modification as a strategy to block protein-protein interactions with small-molecule drugs
    Way, JC
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2000, 4 (01) : 40 - 46
  • [10] Designing small-molecule switches for protein-protein interactions
    Guo, ZH
    Zhou, DM
    Schultz, PG
    SCIENCE, 2000, 288 (5473) : 2042 - +